GITHUB SOFTWARE UK LTD. – Trademark Portfolio
Entity Type: 24
GITHUB SOFTWARE UK LTD. holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 5 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include SEMMLE. The owner is based in OXFORD.
BLUE BOAR COURT, 9 ALFRED STREET
OXFORD OX1 4EH , GB
Showing of trademarks Trademarks
Trademark Classifications
GITHUB SOFTWARE UK LTD.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does GITHUB SOFTWARE UK LTD. have?
GITHUB SOFTWARE UK LTD. has 6 U.S. trademarks filed with the USPTO. Of these, 1 registered, 2 abandoned, 2 cancelled.
What trademark classes does GITHUB SOFTWARE UK LTD. file in?
GITHUB SOFTWARE UK LTD. files trademarks across 3 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 42 (Computer & Scientific), Class 9 (Computers & Electronics). Class 35 covers advertising; business management; business administration; office functions.
What are GITHUB SOFTWARE UK LTD.'s most well-known trademarks?
GITHUB SOFTWARE UK LTD.'s registered trademark portfolio includes well-known marks such as SEMMLE. These are among 1 currently registered trademark in the portfolio.
What is GITHUB SOFTWARE UK LTD.'s trademark registration success rate?
GITHUB SOFTWARE UK LTD. has a 20% trademark registration rate, with 1 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.